PTGS2 and breast cancer: As shown by quantitative PCR, the expression of COX-2 mRNA in the MCF-7 breast cancer cells of the COX-2-shRNA group was significantly lower than that of the blank and mock groups (P<0.05), with no significant difference identified between the mock and blank groups (Fig. 2A).